Health
Second study testing a COVID-19 antibody drug has a setback – Mint
The study can continue to test the antibody drug combo in hospitalized patients who need little or no extra oxygen.Lilly and Regeneron have asked the FDA to allow…
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalized patients.Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavorable balance of risks and benefits.
The study can continue to test the two-antibody…
-
Noosa News13 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News19 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General22 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
General23 hours agoRed tape on chopping block in bid to build homes faster